http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03128383-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D505-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D505-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1990-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6abddd60b06b5fe985aed7168ee8c130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_132b7238ef04d922aec9175dde5a50ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ed3fc2c294af405d2d52426ddc078f
publicationDate 1991-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03128383-A
titleOfInvention Phenacylated pyridiniothiocephalosporin
abstract NEW MATERIAL:A compound expressed by formula I (R 1 is amino or acylamino; R 2 is H or methoxy; R 3 is H; R 4 is vicinal dihydroxylated aryl; R 5 is lower alkylene; R 6 is H, carboxy-protecting group or linked to Y - to form negative charge; X is O, S or sulfinyl; Y - is counter ion of pyridinio group). n EXAMPLE: 3-(1-(3,4-Dihydroxyphenacyl)pyridinio-4-yl)thiomethyl-7β-(2-(2- aminothiazol-4-yl)-2-(1-carboxy-1-methylethoxy)iminoacetamide)-3-cephem-4- carboxylate 1-oxide. n USE: An antimicrobial agent for preventing and treating susceptible infectious diseases. n PREPARATION: For example, an amine expressed by formula II is used as a raw material, amidated and then subjected to heterocyclic group thiation, pyridinio formation, deprotection, esterification, sulfoxidation, sulfoxide cyclization or salt formation. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013002215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013002215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9242999-B2
priorityDate 1989-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88527486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235226494

Total number of triples: 37.